🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Enhancing Renal Graft Function During Donor Anesthesia

RecruitingNAAges 18 Years - 60 YearsAllNazmy Edward Seif
NCT03778944 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplanted kidney. The aim of this study is to assess \& compare the effectiveness of 3 different modalities in this respect: Mannitol, Dopamine and adequate hydration.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * end-stage renal disease, for living-donor kidney transplantation Exclusion Criteria: * severe cardiac or hepatic dysfunction * coagulopathy
💊

What it tests

  • Mannitol infusion
  • Dopamine infusion
  • Adequate hydration
📍

Where

1 site
Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy